Background. Glucagon-like peptide 2 (GLP-2) stimulates intestinal epithelial growth with high potency and specificity. However, the intracellular signaling pathways responsible for the growth-stimulatory action of GLP-2 are not clearly understood. Here we report possible signaling pathways mediating GLP-2's proliferative actions in the human intestinal epithelial cell line Caco-2. Materials and methods. Caco-2 cells were subcultured under serum-deprived conditions in the presence or absence of GLP-2 (10 μM) and varying concentrations of inhibitors of three candidate kinases: genistein, a global tyrosine kinase inhibitor; LY294002, a phosphatidylinositide (PI) 3-kinase inhibitor; and PD 098059, a mitogen- activated/extracellular signal-regulated kinase (MEK) inhibitor. Proliferation was assessed using [3H]thymidine incorporation. Relative abundance of the phosphorylated forms of two specific mitogen-activated protein kinases (MAPKs), ERK1 and ERK2, was assessed by Western blotting. Results. GLP-2-treated cells demonstrated a greater than 10-fold increase in proliferation. This response was inhibited by genistein, LY294002, and PD 098059 in a dose-dependent fashion. A significantly greater abundance of the phosphorylated forms of both ERK-1 and ERK-2 was present in cells within 5 rain of treatment with GLP-2. Conclusions. GLP-2 stimulates the proliferation of Caco-2 cells in vitro. This increase in Caco-2 proliferation in response to GLP-2 may be due, at least in part, to the involvement of both the PI 3- kinase and the MAPK pathways. (C) 2000 Academic Press.
- Glucagon-like peptide 2
- Mitogen-activated protein kinase
- Mitogen-activated/extracellular signal-regulated kinase
- Phosphatidylinositide 3-kinase
- Signal transduction
- Tyrosine kinase
ASJC Scopus subject areas